SNUPHA

Medicinal product

(Invented) name

SNUPHA

Active substance (s)

Ksilometazolino hidrochloridas

Strength

0,5 mg/ml

Pharmaceutical form

nosies purškalas (tirpalas)

Route (s) of administration

vartoti į nosį

Legal status for supply

Nereceptinis

Narrow therapeutic index (NTI)

No

ATC code (s)

R01AA07, Xylometazoline

Marketing authorisation holder

STADA Arzneimittel AG, Vokietija

Date of authorisation

2026-07-17

Date of renewal

Documents

6089_Snupha_0,5.doc

6089_pakuotes lapelis_2026-07-17.doc

Stage

Registruotas

Controlled?

No

Controlled substance type

Legal basis

10a

Procedure number

LV/H/0307/001/DC

Marketing authorisation procedure

Decentralizuota procedūra

Qualitative and quantitative composition

1 ml tirpalo yra	1 ml
Ksilometazolino hidrochloridas	0,5 mg

Packages

PAKID	NPAKID	NPAKID-7	Pack type	Pack size	Type of packaging	Proposed dispensing/classification	Marketing authorisation no.	Supply status	From	To	Package is in foreign language	From	To	Mock-up
121659	107769	1107769	buteliukas	10 ml N1		Nereceptinis	LT/1/26/6089/001	Netiekiama	-	2027-07-01	No	-	-

Stadijos

Data	Stadija
2026-07-17	Registruotas